<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Classification and evaluation of myoclonus</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Classification and evaluation of myoclonus</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Classification and evaluation of myoclonus</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John N Caviness, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Howard I Hurtig, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 07, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION AND DEFINITION</span><span class="headingEndMark"> — </span>Myoclonus is a clinical sign that is characterized by brief, shock-like, involuntary movements caused by muscular contractions or inhibitions [<a href="#rid1">1</a>]. Muscular contractions produce positive myoclonus, whereas muscular inhibitions produce negative myoclonus (ie, asterixis). Patients will usually describe myoclonus as consisting of "jerks," "shakes," or "spasms."</p><p>Myoclonic movements have many possible etiologies, anatomic sources, and pathophysiologic features [<a href="#rid2">2</a>]. Myoclonus may be classified by clinical presentation, examination findings, clinical neurophysiology testing, and etiology.</p><p>This topic will review the classification and evaluation of myoclonus. Treatment is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4888.html" rel="external">"Treatment of myoclonus"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ANATOMIC AND PHYSIOLOGIC CLASSIFICATION</span><span class="headingEndMark"> — </span>In addition to the clinical and etiologic classification discussed below, myoclonus can be classified by the localization of the physiologic mechanism that generates it  (<a class="graphic graphic_table graphicRef62397" href="/z/d/graphic/62397.html" rel="external">table 1</a>). The categories are cortical, cortical-subcortical, subcortical-nonsegmental, segmental, and peripheral.</p><p>This classification paradigm can help with localization of the underlying lesion, aid in the diagnosis of certain disorders that have a characteristic myoclonus physiology, and guide treatment options that may be useful for some physiologic types of myoclonus but not others [<a href="#rid3">3</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cortical</strong> <strong>myoclonus</strong> originates with a focal discharge from the primary sensorimotor cortex, which causes a myoclonic jerk after a time interval required for corticospinal transmission. This type of myoclonus occurs because of insufficient inhibition within neuronal circuits of the primary motor cortex, primary sensory cortex, or both.</p><p></p><p class="bulletIndent1">The detailed body mapping found in the sensorimotor cortex explains the common occurrence of multifocal myoclonus when there is bilateral diffuse dysfunction of the sensorimotor cortex. It likewise explains the occurrence of focal myoclonus when the lesion has a focal distribution. Bisynchronous, generalized myoclonus and generalized tonic-clonic seizures may occur when the focal discharge spreads through cortico-cortico and transcallosal pathways [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1">Cortical myoclonus may occur with reflex sensory stimulation (cortical reflex myoclonus), with muscle activation (cortical action myoclonus), with rest (eg, focal motor seizure), or with any combination of the above.</p><p></p><p class="bulletIndent1">In cortical reflex myoclonus, an exaggerated cortical response to somatosensory stimuli produces the jerk, but subsequently the whole sensorimotor cortex generates giant somatosensory evoked cortical potentials (SEPs) and reflex myoclonus [<a href="#rid5">5</a>]. Rhythmic or semirhythmic discharges from the sensorimotor cortex can produce a repetitive movement that resembles tremor [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">A unifying pathogenic mechanism for cortical myoclonus remains elusive, and there may be mechanism heterogeneity. The relative contribution of intracortical pathology versus abnormal activity projecting into the sensorimotor cortex is not known. Numerous abnormalities have been suspected to be important, including pathways involving GABAergic, serotoninergic, and other neurotransmitters, and cerebellar systems.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cortical-subcortical myoclonus</strong> is the major mechanism for myoclonic seizures that occur in primary generalized epileptic syndromes (eg, juvenile myoclonic epilepsy [JME]) and in some other instances (eg, minipolymyoclonus).</p><p></p><p class="bulletIndent1">With JME and absence epilepsy, thalamic networks are believed to abnormally couple with widespread cortical areas to produce excessive neuronal activity and myoclonic seizures [<a href="#rid7">7,8</a>]. The resulting myoclonic jerks are commonly generalized or bisynchronous.</p><p></p><p class="bulletIndent1">The physiology of cortical-subcortical myoclonus involves abnormal, paroxysmal, and excessive oscillation in bidirectional connections between cortical and subcortical sites.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subcortical-nonsegmental myoclonus</strong> is generated from a site that is subcortical, but the crucial feature is that the myoclonus manifests far beyond the segments that are near the originating site.</p><p></p><p class="bulletIndent1">The best characterized types of subcortical-nonsegmental physiologies are reticular-reflex myoclonus and propriospinal myoclonus. In both of these examples, the abnormal activity begins in a focal area of the neuraxis and then spreads in both rostral and caudal directions, producing generalized myoclonus due to the bilateral pathways involved.</p><p></p><p class="bulletIndent1">There is also evidence of a subcortical-nonsegmental physiology for the myoclonus-dystonia syndrome [<a href="#rid9">9</a>]. The exact subcortical generating site of myoclonus-dystonia is unknown, but the myoclonus distribution extends across the head, neck, upper torso, and bilateral arm segments.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Segmental myoclonus</strong> is generated at a particular segment or contiguous segments of the brainstem and/or spinal cord. The pathologic motor oscillations in this type of myoclonus occur at a lower frequency than what is usually seen in tremor.</p><p></p><p class="bulletIndent1">Segmental myoclonus manifests at, or close to, that particular segment or contiguous segments of the body (eg, palatal myoclonus, spinal segmental myoclonus).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peripheral myoclonus</strong> arises as a consequence of a peripheral nervous system lesion producing hyperactive motor discharges to its muscle (eg, hemifacial spasm). The possible role of central reorganization is not well defined.</p><p></p><p class="headingAnchor" id="H110479156"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>In Olmsted County, Minnesota, the average annual incidence rate for myoclonus was 1.3 cases per 100,000 person-years [<a href="#rid10">10</a>]. The lifetime prevalence of myoclonus in 1990 was 8.6 per 100,000 population. Secondary (symptomatic) myoclonus (72 percent) was the most common clinical category, followed by epileptic myoclonus (17 percent) and essential myoclonus (11 percent) [<a href="#rid10">10</a>].</p><p>Posthypoxic state (Lance-Adams syndrome), neurodegenerative disease, and epilepsy syndromes are the most common causes of myoclonus. Toxic-metabolic and drug-induced cases are particularly common in the hospital setting.</p><p class="headingAnchor" id="H8"><span class="h1">CAUSES</span><span class="headingEndMark"> — </span>The classification scheme of Marsden and colleagues organizes the numerous etiologies of myoclonus into four major categories [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Physiologic</p><p class="bulletIndent1"><span class="glyph">●</span>Essential</p><p class="bulletIndent1"><span class="glyph">●</span>Epileptic</p><p class="bulletIndent1"><span class="glyph">●</span>Secondary (symptomatic)</p><p></p><p>Each clinical category contains myoclonus arising from various etiologies and pathophysiologic mechanisms. Thus, differentiation by clinical-etiologic category is not always pure. In addition, a single etiology can produce different types of myoclonus, and occasional patients may demonstrate more than one type of myoclonus.</p><p>The classification scheme shown in the table  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>) has been modified from the original [<a href="#rid1">1</a>] to account for subsequent discoveries and etiologies.</p><p class="headingAnchor" id="H10"><span class="h2">Physiologic myoclonus</span><span class="headingEndMark"> — </span>Physiologic myoclonus is a normal phenomenon that occurs in healthy people [<a href="#rid1">1</a>]. There is minimal or no associated disability and the physical examination is typically without abnormality.</p><p>The most familiar examples of physiologic myoclonus are jerks during sleep or sleep transitions  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>). Others include anxiety-induced myoclonus, exercise-induced myoclonus, hiccups (singultus), and benign infantile myoclonus with feeding.</p><p class="headingAnchor" id="H11"><span class="h3">Jerks associated with sleep</span><span class="headingEndMark"> — </span>Varieties of sudden movement that occur during sleep or sleep transitions are partial myoclonic jerks, massive myoclonic jerks (hypnic jerks), and periodic movements of sleep [<a href="#rid11">11</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Partial myoclonic jerks are usually multifocal and occur in distal muscles.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Massive myoclonic jerks are generalized and affect trunk and proximal muscles.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Periodic limb movements of sleep (PLMS; nocturnal myoclonus) consist of stereotyped repetitive dorsiflexion of the toes and feet, sometimes with flexion of the knees and hips [<a href="#rid12">12</a>]. The same types of movements occur in the restless legs syndrome (RLS) and can disrupt sleep [<a href="#rid13">13</a>]. When PLMS cause sleep disturbance and/or excessive daytime sleepiness in the absence of another sleep disorder such as RLS, the condition is termed "periodic limb movement disorder" (PLMD). (See  <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">"Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults", section on 'Periodic limb movements of sleep'</a> and  <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">"Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults", section on 'Periodic limb movement disorder'</a>.)</p><p></p><p>Since these types of myoclonus occur around or during sleep, a bed partner is often more aware of the myoclonus than the affected individual.</p><p class="headingAnchor" id="H12"><span class="h2">Essential myoclonus</span><span class="headingEndMark"> — </span>In essential myoclonus, the myoclonus is the most prominent or only clinical finding (ie, an "essential" phenomenon). The patient usually experiences some mild disability. Progression is slow or absent [<a href="#rid1">1</a>]. Cognition is normal.</p><p>Essential myoclonus is divided into sporadic and hereditary forms  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>).</p><p>Sporadic (or idiopathic) essential myoclonus is a heterogeneous entity regarding distribution, exacerbating factors, and findings on neurologic examination [<a href="#rid14">14</a>]. Some cases probably have false-negative family histories and actually represent hereditary disease.</p><p class="headingAnchor" id="H13"><span class="h3">Palatal myoclonus</span><span class="headingEndMark"> — </span>Palatal myoclonus is most often secondary to a brainstem and/or cerebellar lesion. (See  <a class="medical medical_review" href="/z/d/html/4884.html" rel="external">"Symptomatic (secondary) myoclonus", section on 'Palatal myoclonus'</a>.)</p><p>However, some patients have no apparent structural lesion and are considered to have essential palatal myoclonus. In such cases, the myoclonus is usually characterized by contractions of the tensor veli palatini. By contrast, secondary (symptomatic) palatal myoclonus is usually characterized by contractions of the levator veli palatini. Middle ear myoclonus can be either essential or secondary and is characterized by contractions of the tensor tympani and/or stapedius muscles [<a href="#rid15">15-22</a>]. These conditions may cause tinnitus or ear-clicking.</p><p class="headingAnchor" id="H14"><span class="h3">Hereditary essential myoclonus</span><span class="headingEndMark"> — </span>Hereditary essential myoclonus has the following clinical characteristics [<a href="#rid23">23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Onset typically before age 20 years</p><p class="bulletIndent1"><span class="glyph">●</span>Autosomal dominant inheritance with variable expressivity</p><p class="bulletIndent1"><span class="glyph">●</span>A relatively benign course compatible with an active life and normal lifespan</p><p class="bulletIndent1"><span class="glyph">●</span>Absence of cerebellar ataxia, spasticity, dementia, and seizures</p><p></p><p>The myoclonus usually occurs throughout the arms and axial muscles. It is exacerbated by muscle activation and is markedly diminished with alcohol ingestion. Hereditary essential myoclonus demonstrates a subcortical-nonsegmental physiology [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H15"><span class="h3">Myoclonus-dystonia</span><span class="headingEndMark"> — </span>Dystonia is a common feature of hereditary essential myoclonus, and when present, the condition is termed "myoclonus-dystonia syndrome." In addition to myoclonus, this syndrome is characterized by dystonia of variable, but typically mild, severity that often presents as cervical and/or limb dystonia [<a href="#rid24">24</a>]. The mean age of symptom onset is six years [<a href="#rid25">25</a>], occurring earlier in girls than in boys (median five versus eight years) [<a href="#rid26">26</a>]. Although unusual after age 20, onset as late as 75 years has been reported [<a href="#rid27">27</a>].</p><p>In a prospective report of 41 patients with myoclonus-dystonia syndrome and mutations of the sarcoglycan epsilon (<em>SGCE</em> or DYT11) gene on chromosome 7q21, the myoclonus was predominantly localized to the neck and trunk or proximal upper limbs [<a href="#rid25">25</a>]. The myoclonic movements consisted of short jerks (mean duration 95 ms, range 25 to 256 ms) occurring at rest, during action, and during posture. Myoclonus was either isolated or associated with mild to moderate dystonia. Twenty-two percent of patients had spontaneous improvement in dystonia lasting 1 to 20 years. In a separate cohort of 49 patients with <em>SGCE</em>-related myoclonus-dystonia, the most common early dystonia pattern was task specific, involving writing, walking, and/or running [<a href="#rid28">28</a>].</p><p>In most cases, myoclonus-dystonia confers little or no functional disability and is compatible with a normal lifespan [<a href="#rid24">24,29</a>]. However, the course is unpredictable, and a minority of patients develops progressive symptoms that can lead to severe motor disability [<a href="#rid24">24,29,30</a>]. Patients with writer’s cramp in childhood often have handwriting disability that may benefit from assistive technology and botulinum toxin injections in some cases [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/4887.html" rel="external">"Treatment of dystonia in children and adults", section on 'Focal dystonia in children'</a>.)</p><p>Myoclonus-dystonia is genetically heterogeneous. Mutations involving the <em>SGCE</em> gene are the most frequent identified cause but are found in less than one-half of cases [<a href="#rid31">31-35</a>]. Small studies have identified other putative genetic causes including mutations in the reelin (<em>RELN</em>) gene [<a href="#rid36">36</a>], the calcium voltage-gated channel subunit alpha1 B (<em>CACNA1B</em>) gene [<a href="#rid37">37</a>], the tyrosine hydroxylase (<em>TH</em>) gene [<a href="#rid38">38</a>], and the DYT15 locus on chromosome 18p11 [<a href="#rid39">39</a>]. Additional genes are likely to be associated with this syndrome.</p><p>Some <em>SGCE</em> mutation carriers have psychiatric disturbances, mainly obsessive-compulsive disorder and alcohol dependence [<a href="#rid40">40-43</a>].</p><p>In contrast to other types of sarcoglycan, which are expressed mainly in muscle and are associated with muscular dystrophy, epsilon-sarcoglycan is expressed in the brain and other non-muscle tissues, but its normal function is unknown [<a href="#rid31">31</a>]. Most <em>SGCE</em> mutations are "loss of function," and maternal imprinting has been associated with reduced penetrance [<a href="#rid44">44</a>]. Exactly how the loss of <em>SGCE</em> function results in myoclonus or dystonia is not known, but epsilon-sarcoglycan has been localized to areas important for movement, such as the cerebellum and monoamine brainstem nuclei, including dopaminergic neurons [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Epileptic myoclonus</span><span class="headingEndMark"> — </span>Epileptic myoclonus refers to the presence of myoclonus in the setting of epilepsy  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>). Seizures dominate the clinical picture in epileptic myoclonus. The etiology may be idiopathic, genetic, or a static encephalopathy.</p><p>Myoclonus can occur as either one of several components of a seizure, the only seizure manifestation (myoclonic seizure), or one of multiple seizure types within an epileptic syndrome. Different types of epileptic myoclonus may demonstrate a cortical or cortical-subcortical physiology.</p><p class="headingAnchor" id="H17"><span class="h3">Fragments of epilepsy</span><span class="headingEndMark"> — </span>"Fragments of epilepsy" designates myoclonic jerks in patients with epilepsy where myoclonus is not the main seizure phenotype and includes the following examples  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Isolated epileptic myoclonic jerks</p><p class="bulletIndent1"><span class="glyph">●</span>Epilepsia partialis continua (focal status epilepticus)</p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic stimulus-sensitive myoclonus</p><p class="bulletIndent1"><span class="glyph">●</span>Photosensitive myoclonus</p><p class="bulletIndent1"><span class="glyph">●</span>Absences with a minor myoclonic component</p><p class="bulletIndent1"><span class="glyph">●</span>Epilepsy with myoclonic absences</p><p></p><p>In epilepsia partialis continua, the myoclonus is spontaneous and focal; it occurs irregularly or regularly at intervals no longer than 10 seconds, is confined to one part of the body, and continues for a period of hours, days, or weeks [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H18"><span class="h3">Myoclonic epilepsy syndromes</span><span class="headingEndMark"> — </span>Myoclonus is the main seizure phenotype associated with a number of epilepsy syndromes that mostly present in infancy or childhood  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Infantile spasms (West syndrome)</p><p class="bulletIndent1"><span class="glyph">●</span>Severe myoclonic epilepsy of infancy (Dravet syndrome)</p><p class="bulletIndent1"><span class="glyph">●</span>Benign myoclonic epilepsy of infancy</p><p class="bulletIndent1"><span class="glyph">●</span>Lennox-Gastaut syndrome</p><p class="bulletIndent1"><span class="glyph">●</span>Myoclonic astatic epilepsy (Doose syndrome)</p><p class="bulletIndent1"><span class="glyph">●</span>Cryptogenic myoclonus epilepsy (Aicardi)</p><p class="bulletIndent1"><span class="glyph">●</span>Juvenile myoclonic epilepsy (JME; Janz syndrome)</p><p class="bulletIndent1"><span class="glyph">●</span>Familial cortical myoclonic tremor with epilepsy</p><p></p><p>In myoclonic seizures, the characteristic seizure movement manifestation is myoclonus. They may be confused with other seizures that result in jerks (eg, atonic and tonic seizures). In myoclonic epilepsy syndromes, myoclonic seizures are usually accompanied by other seizure types, such as generalized tonic-clonic and/or absence in patients with JME. Uncommonly, myoclonus is the only seizure type and abnormal electroencephalography (EEG) or family history of epilepsy points to the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/17192.html" rel="external">"Juvenile myoclonic epilepsy", section on 'Clinical features'</a>.)</p><p>True myoclonic seizures result in brief positive myoclonus [<a href="#rid7">7</a>]. Patients may be thought to be "clumsy" before the pathological nature of their symptoms is appreciated. On EEG, the myoclonus is accompanied by a generalized (primary or secondary) ictal epileptiform discharge, but the myoclonus itself may be generalized, segmental, or focal.</p><p>Myoclonic seizures occurring in a primary generalized epileptic syndrome exhibit a cortical-subcortical physiology, while those occurring in a secondary generalized epileptic syndrome exhibit a cortical physiology with a tendency to spread.</p><p>The genetics of the myoclonic epilepsies is heterogeneous, but in many instances, mutations have been found in ion channels or neurotransmitter receptor genes [<a href="#rid47">47,48</a>].</p><p class="headingAnchor" id="H19"><span class="h3">Familial cortical myoclonic tremor with epilepsy</span><span class="headingEndMark"> — </span>The term "familial cortical myoclonic tremor with epilepsy" encompasses a large number of syndrome labels  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>) used to describe a genetically heterogeneous phenotype with the following core clinical features [<a href="#rid49">49-52</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Autosomal dominant inheritance</p><p class="bulletIndent1"><span class="glyph">●</span>Adult onset</p><p class="bulletIndent1"><span class="glyph">●</span>Distal action tremor and myoclonus</p><p class="bulletIndent1"><span class="glyph">●</span>Infrequent, secondarily generalized tonic-clonic seizures</p><p class="bulletIndent1"><span class="glyph">●</span>Relatively benign course, typically with normal cognition</p><p class="bulletIndent1"><span class="glyph">●</span>Responsiveness to anticonvulsants</p><p></p><p>Occasional patients with this syndrome may exhibit frequent seizures, other seizure types, larger arrhythmic myoclonic jerks, or abnormal cognition.</p><p>Clinical neurophysiology testing reveals distal rhythmic small-amplitude myoclonus (tremor) with action (voluntary movement) produced by electromyographic (EMG) discharges exhibiting a cortical physiology. Additional typical features are enlarged (giant) somatosensory evoked potentials (SEPs) and enhanced long-latency EMG reflexes at rest, consistent with cortical reflex myoclonus [<a href="#rid53">53</a>].</p><p>Most of the reported pedigrees are in Japanese and European populations. Causative mutations span several different genes and seemingly unrelated gene products [<a href="#rid52">52</a>]. A common molecular pathology may relate to noncoding intronic repeat expansions and RNA toxicity [<a href="#rid52">52,54</a>].</p><p class="headingAnchor" id="H34491582"><span class="h2">Primary myoclonus</span><span class="headingEndMark"> — </span>Isolated myoclonus is seen in primary progressive myoclonus of aging and familial cortical myoclonus.</p><p class="headingAnchor" id="H34491589"><span class="h3">Primary progressive myoclonus of aging</span><span class="headingEndMark"> — </span>Older individuals may develop a progressive isolated myoclonus without any cause or other syndrome being identified, a condition termed "primary progressive myoclonus of aging" [<a href="#rid55">55</a>]. There is a progressive development of focal/asymmetric predominantly action myoclonus. The progression of the myoclonus may plateau once it is severe. The physiology is uniformly cortical with variable reflex features. These cases do respond to a cortical physiology treatment approach. (See  <a class="medical medical_review" href="/z/d/html/4888.html" rel="external">"Treatment of myoclonus", section on 'Cortical myoclonus'</a>.)</p><p>The association with older individuals suggests that primary progressive myoclonus of aging is a neurodegenerative syndrome, but the etiology awaits clarification. The cause of this syndrome is probably heterogeneous, and no autopsies have been reported.</p><p class="headingAnchor" id="H34491596"><span class="h3">Familial cortical myoclonus</span><span class="headingEndMark"> — </span>Familial cortical myoclonus, described in one large Mennonite family from Canada, is an autosomal dominant condition with onset from the second to seventh decade of life, and has been tentatively linked to a mutation in the nucleolar protein 3 (<em>NOL3</em>) gene [<a href="#rid56">56</a>]. The phenotype is characterized by a slowly progressive, stimulus-evoked, multifocal cortical myoclonus involving the face and limbs that becomes disabling late in the course. Neither seizures nor dystonia have been observed.</p><p class="headingAnchor" id="H20"><span class="h3">Symptomatic myoclonus</span><span class="headingEndMark"> — </span>Myoclonus that occurs as a secondary symptom of a neurologic or nonneurologic disorder has been traditionally termed "symptomatic."</p><p>Symptomatic myoclonus can occur in association with conditions that span the entire spectrum of neurologic disease  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>). Major categories include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Drug-induced and toxic syndromes</p><p class="bulletIndent1"><span class="glyph">●</span>Encephalopathies, including hypoxia [<a href="#rid57">57</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Neurodegenerative diseases</p><p class="bulletIndent1"><span class="glyph">●</span>Focal nervous system damage</p><p class="bulletIndent1"><span class="glyph">●</span>Progressive myoclonic epilepsy</p><p class="bulletIndent1"><span class="glyph">●</span>Progressive myoclonus ataxia</p><p class="bulletIndent1"><span class="glyph">●</span>Infectious and postinfectious disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Autoimmune inflammatory disorders, including opsoclonus-myoclonus syndrome</p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Disorders that affect multiple organ systems, including mitochondrial disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Storage diseases</p><p class="bulletIndent1"><span class="glyph">●</span>Exaggerated startle syndromes</p><p class="bulletIndent1"><span class="glyph">●</span>Psychogenic jerks</p><p></p><p>Often there is clinical or pathologic evidence of diffuse nervous system involvement. This category is reviewed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/4884.html" rel="external">"Symptomatic (secondary) myoclonus"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Guidelines for the evaluation of a patient with myoclonus may be conceptualized into four parts:</p><p class="bulletIndent1"><span class="glyph">●</span>Syndrome identification based upon clinical features</p><p class="bulletIndent1"><span class="glyph">●</span>Ancillary laboratory testing</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical neurophysiology</p><p class="bulletIndent1"><span class="glyph">●</span>Testing for rare causes of myoclonus</p><p></p><p class="headingAnchor" id="H22"><span class="h2">Syndrome identification</span><span class="headingEndMark"> — </span>The initial steps in the evaluation of a patient with myoclonus are the history and examination, as outlined in the table  (<a class="graphic graphic_table graphicRef51320" href="/z/d/graphic/51320.html" rel="external">table 3</a>). The findings should identify which major clinical and etiologic classification (physiologic, essential, epileptic, or secondary myoclonus) best reflects the circumstances of the patient  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>) [<a href="#rid1">1</a>].</p><p>Most myoclonic movements are easily diagnosed by clinical observation [<a href="#rid58">58</a>]. The examination of a patient with myoclonus should delineate the distribution, temporal profile, and activation characteristics of the myoclonic movement.</p><p class="bulletIndent1"><span class="glyph">●</span>The distribution can be focal, multifocal, segmental, or generalized. A multifocal distribution may have bilaterally synchronous movements as well.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The temporal profile can be continuous or intermittent, as well as rhythmic or irregular. Intermittent myoclonus can occur as isolated or repetitive trains of jerks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The activation of the myoclonus may be at rest (spontaneous), induced by various stimuli (reflex myoclonus), induced by voluntary movement (action myoclonus), or some combination of these. All the possible activation characteristics should be noted as absent or present.</p><p></p><p>Occasionally, it may be difficult to differentiate myoclonus from other involuntary movements (eg, chorea, dystonia, tremor, tics) by observation [<a href="#rid58">58</a>]. Myoclonus is most easily confused with tics, though tics are usually repetitive, stereotypic, and semi-voluntary. In this situation, clinical neurophysiology studies can be particularly helpful [<a href="#rid58">58</a>]. (See <a class="local">'Clinical neurophysiology'</a> below.)</p><p>Myoclonus induced by drugs or toxins is potentially treatable, since the myoclonus typically resolves upon withdrawal of the offending agent(s). It is important to scrutinize all drugs,<em> </em>either in isolation or combination, when evaluating for a potential causative role in myoclonus. Agents most often associated with myoclonus include (see  <a class="medical medical_review" href="/z/d/html/4884.html" rel="external">"Symptomatic (secondary) myoclonus", section on 'Drug-induced and toxic syndromes'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Levodopa</p><p class="bulletIndent1"><span class="glyph">●</span>Psychiatric medications (eg, tricyclic antidepressants, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Antibiotics (eg, penicillins, cephalosporins, quinolones)</p><p class="bulletIndent1"><span class="glyph">●</span>Narcotics</p><p class="bulletIndent1"><span class="glyph">●</span>Anticonvulsants</p><p class="bulletIndent1"><span class="glyph">●</span>Anesthetics</p><p class="bulletIndent1"><span class="glyph">●</span>Contrast media</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac medications (eg, calcium channel blockers, antiarrhythmic agents)</p><p class="bulletIndent1"><span class="glyph">●</span>Drug withdrawal from certain agents (eg, sedatives)</p><p></p><p class="headingAnchor" id="H23"><span class="h2">Ancillary studies</span><span class="headingEndMark"> — </span>Ancillary testing should be performed if the myoclonus etiology is unclear from the history and examination findings. Suggested studies are as follows [<a href="#rid59">59-61</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Electrolytes (including calcium and magnesium)</p><p class="bulletIndent1"><span class="glyph">●</span>Bismuth</p><p class="bulletIndent1"><span class="glyph">●</span>Glucose</p><p class="bulletIndent1"><span class="glyph">●</span>Renal function tests</p><p class="bulletIndent1"><span class="glyph">●</span>Liver function tests</p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid antibodies and thyroid function tests</p><p class="bulletIndent1"><span class="glyph">●</span>Paraneoplastic antibodies (comprehensive panel)</p><p class="bulletIndent1"><span class="glyph">●</span>Vitamin E level</p><p class="bulletIndent1"><span class="glyph">●</span>Drug and toxin screen if clinical suspicion of undisclosed substance intake or use of illicit or prescribed psychoactive medications</p><p class="bulletIndent1"><span class="glyph">●</span>Electroencephalography (EEG)</p><p class="bulletIndent1"><span class="glyph">●</span>Brain imaging</p><p class="bulletIndent1"><span class="glyph">●</span>Spine imaging if there is focal or segmental myoclonus</p><p class="bulletIndent1"><span class="glyph">●</span>Infection workup (complete blood count, urinalysis, chest radiograph, blood cultures, lumbar puncture) if localizing signs of fever, leukocytosis, or encephalopathy</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebrospinal fluid analysis in cases with encephalopathy, signs of infection, suspicion for immune-mediated disorder, or suspicion for prion disease (eg, Creutzfeldt-Jakob disease)</p><p></p><p>Such testing covers the most common disturbances of electrolyte balance and acquired metabolic disorders that can cause myoclonus. Imaging of the brain and spinal cord may reveal lesions or atrophy supporting a specific myoclonus etiology. Cerebrospinal fluid analysis is useful to differentiate an infectious/inflammatory etiology from a toxic, drug-induced, or metabolic etiology.</p><p>EEG can identify both ictal and interictal patterns in the epileptic myoclonus category. As examples, generalized spikes and a 3 to 6 Hz spike-and-wave pattern are typical for primary generalized myoclonic epilepsy, whereas a 3 Hz spike-and-wave is seen in absence epilepsy syndromes.</p><p class="headingAnchor" id="H24"><span class="h2">Clinical neurophysiology</span><span class="headingEndMark"> — </span>When the diagnosis and physiology of myoclonus remain unclear after the initial evaluation above, clinical neurophysiology testing  (<a class="graphic graphic_table graphicRef129393" href="/z/d/graphic/129393.html" rel="external">table 4</a>) is useful to determine the physiologic classification of myoclonus and support or confirm the neuroanatomic localization and etiology  (<a class="graphic graphic_table graphicRef56405" href="/z/d/graphic/56405.html" rel="external">table 5</a>). In addition, it is helpful when clinical observation alone is unable to distinguish myoclonus from other involuntary movements such as chorea, dystonia, and tremor [<a href="#rid58">58</a>].</p><p>When using multiple techniques for physiologic classification of myoclonus, the results from the EEG obtained in basic ancillary testing (discussed above) are combined with the following methods [<a href="#rid3">3,58</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Surface electromyography (EMG)</p><p class="bulletIndent1"><span class="glyph">●</span>Simultaneous EEG-EMG polygraphy</p><p class="bulletIndent1"><span class="glyph">●</span>Somatosensory evoked potentials (SEPs)</p><p class="bulletIndent1"><span class="glyph">●</span>Jerk-locked back-averaging of EEG transients and/or SEPs to EMG discharges</p><p class="bulletIndent1"><span class="glyph">●</span>Long-latency EMG responses to peripheral nerve stimulation (eg, C reflex)</p><p></p><p>Surface EMG recording can demonstrate the abrupt and brief muscle contraction that is characteristic of positive myoclonus [<a href="#rid58">58</a>]. In addition, EMG can reveal the silent period of negative myoclonus (asterixis).</p><p>EEG-EMG polygraphy (ie, the combined, simultaneous recording of EEG and surface EMG) is the most important clinical neurophysiology study, since it can show the approximate relationship of EEG activity with myoclonus, and determine which muscles are most frequently involved with the myoclonic jerks [<a href="#rid58">58</a>]. As an example, jerk-locked back-averaging of EEG waveforms to EMG discharges can detect small EEG potentials that are temporally related to myoclonus [<a href="#rid58">58</a>].</p><p>We suggest clinical neurophysiology testing if a diagnosis is not forthcoming after the history, examination, and ancillary testing are performed. The treatment implications of physiologic classification are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4888.html" rel="external">"Treatment of myoclonus"</a>.)</p><p>Major categories of the physiologic classification used here primarily refer to the neuroanatomic source of the myoclonus. (See <a class="local">'Anatomic and physiologic classification'</a> above.)</p><p class="headingAnchor" id="H25"><span class="h3">Findings associated with major anatomic-physiologic categories</span><span class="headingEndMark"> — </span>The basic clinical neurophysiology findings for each major anatomic-physiologic category of myoclonus are discussed here briefly and are summarized in the tables  (<a class="graphic graphic_table graphicRef56405" href="/z/d/graphic/56405.html" rel="external">table 5</a> and <a class="graphic graphic_table graphicRef51170" href="/z/d/graphic/51170.html" rel="external">table 6</a>) [<a href="#rid3">3,58</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Cortical – Cortical myoclonus originates as a focal discharge from the primary sensorimotor cortex. The EMG discharge duration is typically &lt;75 ms, and a focal back-averaged EEG transient is present. Enlarged (giant) SEPs and enhanced long-latency EMG responses (eg, the C reflex) are characteristic of cortical reflex myoclonus physiology.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cortical-subcortical – The physiology of cortical-subcortical myoclonus involves abnormal, paroxysmal, and excessive oscillation in bidirectional connections between cortical and subcortical sites. On surface EMG, discharge duration is typically &lt;100 ms, and the associated EEG transient (eg, spike-and-wave) is usually diffuse. With back-averaging, time-locked correlation of EEG transients to EMG discharges is typical. Giant SEPs and enhanced long-latency reflexes are sometimes seen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Subcortical-nonsegmental – Subcortical-nonsegmental myoclonus is generated from subcortical but not segmental sources (eg, myoclonus-dystonia syndrome). Variable EMG discharge duration is characteristic. Jerk-locked back-averaging shows no correlation of EEG transients to EMG discharges. SEPs are normal. Some cases have an EMG reflex response to sound stimulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Segmental – Segmental myoclonus is generated at a particular segment or contiguous segments of the brainstem and/or spinal cord. EMG discharge duration is typically &gt;100 ms. There are usually rhythmic EMG discharges. With EMG reflex testing, some types of segmental myoclonus may show a very short latency response that is incompatible with a supraspinal origin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral – Peripheral myoclonus is driven from a peripheral site (ie, a peripheral nerve). Variable EMG discharge duration and irregularity is characteristic.</p><p></p><p class="headingAnchor" id="H26"><span class="h2">Testing for rare causes of myoclonus</span><span class="headingEndMark"> — </span>Additional testing for conditions that rarely cause myoclonus may be needed when the standard evaluation, including clinical neurophysiology studies, fails to reveal a cause. Some examples include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Body imaging for occult cancer, even in the absence of paraneoplastic antibodies (eg, suggested by older age, a rapid decline in general health, and/or weight loss) (see  <a class="medical medical_review" href="/z/d/html/5188.html" rel="external">"Overview of paraneoplastic syndromes of the nervous system", section on 'Diagnostic evaluation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for malabsorption disorders such as celiac sprue and Whipple's disease (eg, suggested by diarrhea, gastric distress, and/or weight loss) (see  <a class="medical medical_review" href="/z/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2702.html" rel="external">"Whipple's disease", section on 'Differential diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enzyme assays for neuraminidase deficiency (sialidosis) and biotinidase deficiency (multiple carboxylase deficiency; eg, suggested by ataxia, cherry red spot in macula, hearing/vision loss, and/or skin rash) (see  <a class="medical medical_review" href="/z/d/html/6234.html" rel="external">"Overview of the hereditary ataxias", section on 'Sialidosis'</a> and  <a class="medical medical_review" href="/z/d/html/5367.html" rel="external">"Overview of water-soluble vitamins", section on 'Multiple carboxylase deficiency'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for Wilson disease (eg, suggested by the presence of liver disease, Kayser-Fleischer rings, or extrapyramidal movement disorders, and/or young age) (see  <a class="medical medical_review" href="/z/d/html/83837.html" rel="external">"Wilson disease: Clinical manifestations, diagnosis, and natural history"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for ataxia-telangiectasia (eg, suggested by the presence of ataxia, telangiectasia, immunodeficiency, and/or a cancer predisposition) (see  <a class="medical medical_review" href="/z/d/html/6233.html" rel="external">"Ataxia-telangiectasia", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genetic testing (and tissue biopsy if indicated) for inherited disorders, such as Unverricht-Lundborg disease (cystatin B [<em>CSTB</em>] gene), Lafora body disease (<em>EPM2A</em> and <em>EPM2B</em> genes), neuronal ceroid lipofuscinosis, and Huntington disease (eg, suggested by family history, seizures, young onset, and progression) (see  <a class="medical medical_review" href="/z/d/html/4907.html" rel="external">"Huntington disease: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for mitochondrial disorders, including serum lactate, muscle biopsy, and genetic testing (eg, suggested by family history, multiple organ system failure, hearing/vision problems, ataxia, muscle weakness, and/or lipomas) (see  <a class="medical medical_review" href="/z/d/html/5151.html" rel="external">"Mitochondrial myopathies: Clinical features and diagnosis", section on 'Evaluation and diagnosis'</a>)</p><p></p><p>The choice and order of such testing is guided by the clinical circumstances and suspicion for a specific diagnosis or group of etiologies. Of note, a paraneoplastic antibody screen is a basic evaluation when the etiology of the myoclonus is unclear, since it is less expensive than an extensive imaging screen. Detection of a paraneoplastic antibody can direct the workup for particular underlying neoplasms. However, cases of paraneoplastic myoclonus can occur without the presence of a known antibody; the corollary is that failure to detect a paraneoplastic antibody does not exclude a paraneoplastic syndrome. Therefore, imaging for occult malignancy is necessary if no etiology for myoclonus has been identified. In children with typical opsoclonus-myoclonus syndrome, evaluation for neuroblastoma should proceed regardless of the antibody screen.</p><p class="headingAnchor" id="H306980559"><span class="h2">Inpatient evaluation of new-onset myoclonus</span><span class="headingEndMark"> — </span>For hospitalized patients with new or recent onset of myoclonus, the most common causes are toxic-metabolic and drug-induced etiologies. The initial evaluation should focus on these potential causes and look for subacute or acute systemic and neurologic conditions that are associated with myoclonus  (<a class="graphic graphic_algorithm graphicRef113639" href="/z/d/graphic/113639.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H286621943"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/82945.html" rel="external">"Patient education: Myoclonus (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H27"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Myoclonus is characterized by brief, shock-like, involuntary movements caused by muscular contractions or inhibitions. Muscular contractions produce positive myoclonus, whereas muscular inhibitions produce negative myoclonus (asterixis). (See <a class="local">'Introduction and definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical/etiologic classification</strong> – The clinical and etiologic classification scheme uses four major categories to organize myoclonus  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>) (see <a class="local">'Causes'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physiologic myoclonus</strong> – Physiologic myoclonus is a normal phenomenon that can occur in healthy people. There is minimal or no associated disability and the physical examination is typically without abnormality. The most familiar examples of physiologic myoclonus are jerks during sleep or sleep transitions  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>). (See <a class="local">'Physiologic myoclonus'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Essential myoclonus</strong> – In essential myoclonus, the myoclonus is the most prominent or only clinical finding. Hereditary and sporadic forms exist  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>). (See <a class="local">'Essential myoclonus'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epileptic myoclonus </strong>–<strong> </strong>Epileptic myoclonus refers to the presence of myoclonus in the setting of epilepsy  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>). Seizures dominate the clinical picture in epileptic myoclonus. The etiology may be idiopathic, genetic, or a static encephalopathy. Subcategories of epileptic myoclonus include the following (see <a class="local">'Epileptic myoclonus'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Fragments of epilepsy, in which myoclonus is not the main seizure phenotype</p><p class="bulletIndent3"><span class="glyph">-</span>Myoclonic epilepsy syndromes</p><p class="bulletIndent3"><span class="glyph">-</span>Familial cortical myoclonic tremor with epilepsy</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic myoclonus</strong> – Symptomatic myoclonus is the most common type of myoclonus. It occurs as a secondary symptom of a neurologic or nonneurologic disorder. Symptomatic myoclonus can occur in association with conditions that span the entire spectrum of neurologic disease  (<a class="graphic graphic_table graphicRef78331" href="/z/d/graphic/78331.html" rel="external">table 2</a>). (See <a class="local">'Symptomatic myoclonus'</a> above.)</p><p></p><p class="bulletIndent2">Symptomatic myoclonus is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/4884.html" rel="external">"Symptomatic (secondary) myoclonus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomic/physiologic classification</strong> – The anatomic and physiologic classification scheme categorizes myoclonus according to the localization of the mechanism that generates it  (<a class="graphic graphic_table graphicRef62397" href="/z/d/graphic/62397.html" rel="external">table 1</a>). The categories are cortical, cortical-subcortical, subcortical-nonsegmental, segmental, and peripheral. (See <a class="local">'Anatomic and physiologic classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation </strong>–<strong> </strong>Guidelines for the evaluation of a patient with myoclonus may be conceptualized into four parts  (<a class="graphic graphic_table graphicRef51320" href="/z/d/graphic/51320.html" rel="external">table 3</a>) (see <a class="local">'Evaluation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Syndrome identification</strong> – Most myoclonic movements are easily diagnosed by clinical observation. The examination of a patient with myoclonus should delineate the distribution, temporal profile, and activation characteristics of the myoclonus  (<a class="graphic graphic_table graphicRef51170" href="/z/d/graphic/51170.html" rel="external">table 6</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ancillary laboratory testing</strong> – Ancillary testing should be performed if the etiology remains unclear. (See <a class="local">'Syndrome identification'</a> above and <a class="local">'Ancillary studies'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical neurophysiology</strong> – Neurophysiology testing is useful when clinical observation alone is unable to distinguish myoclonus from other involuntary movements such as chorea, dystonia, and tremor  (<a class="graphic graphic_table graphicRef56405" href="/z/d/graphic/56405.html" rel="external">table 5</a>). Simultaneous electroencephalography-electromyography (EEG-EMG) polygraphy is the most important clinical neurophysiology study, since it can show the approximate relationship of EEG activity with myoclonus, and determine which muscles are most frequently involved with the myoclonic jerks. (See <a class="local">'Clinical neurophysiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Testing for rare causes</strong> – Additional testing for conditions that rarely cause myoclonus may be needed when the standard evaluation, including clinical neurophysiology studies, fails to reveal a cause. (See <a class="local">'Testing for rare causes of myoclonus'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. In: Movement Disorders, Marsden CD, Fahn S (Eds), Butterworths, London 1982. p.196.</li><li><a class="nounderline abstract_t">Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol 2004; 3:598.</a></li><li class="breakAll">Caviness JN. Clinical neurophysiology of myoclonus. In: Handbook of Clinical Neurophysiology, Vol 1: Movement Disorders, Hallett M (Ed), Elsevier, Amsterdam 2003. p.521.</li><li><a class="nounderline abstract_t">Brown P, Day BL, Rothwell JC, et al. Intrahemispheric and interhemispheric spread of cerebral cortical myoclonic activity and its relevance to epilepsy. Brain 1991; 114 ( Pt 5):2333.</a></li><li><a class="nounderline abstract_t">Hitomi T, Ikeda A, Matsumoto R, et al. Generators and temporal succession of giant somatosensory evoked potentials in cortical reflex myoclonus: epicortical recording from sensorimotor cortex. Clin Neurophysiol 2006; 117:1481.</a></li><li><a class="nounderline abstract_t">Ikeda A, Kakigi R, Funai N, et al. Cortical tremor: a variant of cortical reflex myoclonus. Neurology 1990; 40:1561.</a></li><li><a class="nounderline abstract_t">Guerrini R, Bonanni P, Parmeggiani L, et al. Pathophysiology of myoclonic epilepsies. Adv Neurol 2005; 95:23.</a></li><li><a class="nounderline abstract_t">Snead OC 3rd. Basic mechanisms of generalized absence seizures. Ann Neurol 1995; 37:146.</a></li><li><a class="nounderline abstract_t">Nitschke MF, Erdmann C, Trillenberg P, et al. Functional MRI reveals activation of a subcortical network in a 5-year-old girl with genetically confirmed myoclonus-dystonia. Neuropediatrics 2006; 37:79.</a></li><li><a class="nounderline abstract_t">Caviness JN, Alving LI, Maraganore DM, et al. The incidence and prevalence of myoclonus in Olmsted County, Minnesota. Mayo Clin Proc 1999; 74:565.</a></li><li><a class="nounderline abstract_t">Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Nocturnal myoclonus and restless legs syndrome. Adv Neurol 1986; 43:295.</a></li><li class="breakAll">Marsden CD, Fahn S. Problems in the dyskinesias. In: Movement Disorders, Marsden CE, Fahn S (Eds), Butterworths, London 1987. Vol 2, p.305.</li><li><a class="nounderline abstract_t">Krueger BR. Restless legs syndrome and periodic movements of sleep. Mayo Clin Proc 1990; 65:999.</a></li><li><a class="nounderline abstract_t">Bressman S, Fahn S. Essential myoclonus. Adv Neurol 1986; 43:287.</a></li><li><a class="nounderline abstract_t">Wakata N, Sugimoto H, Iguchi H, et al. A case of voluntary palatal myoclonus with ear click: relationship between palatal myoclonus and click. Eur Neurol 2002; 48:52.</a></li><li><a class="nounderline abstract_t">Fabiani G, Teive HA, Sá D, et al. Palatal myoclonus: report of two cases. Arq Neuropsiquiatr 2000; 58:901.</a></li><li><a class="nounderline abstract_t">Kutukcu Y, Imirzalioglu N, Odabasi Z, et al. Essential palatal myoclonus in monozygotic male twins. J Neurol 2003; 250:885.</a></li><li><a class="nounderline abstract_t">Bento RF, Sanchez TG, Miniti A, Tedesco-Marchesi AJ. Continuous, high-frequency objective tinnitus caused by middle ear myoclonus. Ear Nose Throat J 1998; 77:814.</a></li><li><a class="nounderline abstract_t">Golz A, Fradis M, Netzer A, et al. Bilateral tinnitus due to middle-ear myoclonus. Int Tinnitus J 2003; 9:52.</a></li><li><a class="nounderline abstract_t">Golz A, Fradis M, Martzu D, et al. Stapedius muscle myoclonus. Ann Otol Rhinol Laryngol 2003; 112:522.</a></li><li><a class="nounderline abstract_t">Oliveira CA, Negreiros Júnior J, Cavalcante IC, et al. Palatal and middle-ear myoclonus: a cause for objective tinnitus. Int Tinnitus J 2003; 9:37.</a></li><li><a class="nounderline abstract_t">Bhimrao SK, Masterson L, Baguley D. Systematic review of management strategies for middle ear myoclonus. Otolaryngol Head Neck Surg 2012; 146:698.</a></li><li><a class="nounderline abstract_t">Mahloudji M, Pikielny RT. Hereditary essential myoclonus. Brain 1967; 90:669.</a></li><li><a class="nounderline abstract_t">Kinugawa K, Vidailhet M, Clot F, et al. Myoclonus-dystonia: an update. Mov Disord 2009; 24:479.</a></li><li><a class="nounderline abstract_t">Roze E, Apartis E, Clot F, et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008; 70:1010.</a></li><li><a class="nounderline abstract_t">Raymond D, Saunders-Pullman R, de Carvalho Aguiar P, et al. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. Mov Disord 2008; 23:588.</a></li><li><a class="nounderline abstract_t">Foncke EM, Gerrits MC, van Ruissen F, et al. Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia. Neurology 2006; 67:1677.</a></li><li><a class="nounderline abstract_t">Correa-Vela M, Carvalho J, Ferrero-Turrion J, et al. Early recognition of SGCE-myoclonus-dystonia in children. Dev Med Child Neurol 2023; 65:207.</a></li><li><a class="nounderline abstract_t">Kurlan R, Behr J, Medved L, Shoulson I. Myoclonus and dystonia: a family study. Adv Neurol 1988; 50:385.</a></li><li><a class="nounderline abstract_t">Quinn NP. Essential myoclonus and myoclonic dystonia. Mov Disord 1996; 11:119.</a></li><li><a class="nounderline abstract_t">Asmus F, Gasser T. Inherited myoclonus-dystonia. Adv Neurol 2004; 94:113.</a></li><li><a class="nounderline abstract_t">Han F, Lang AE, Racacho L, et al. Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families. Neurology 2003; 61:244.</a></li><li><a class="nounderline abstract_t">Schüle B, Kock N, Svetel M, et al. Genetic heterogeneity in ten families with myoclonus-dystonia. J Neurol Neurosurg Psychiatry 2004; 75:1181.</a></li><li><a class="nounderline abstract_t">Tezenas du Montcel S, Clot F, Vidailhet M, et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet 2006; 43:394.</a></li><li><a class="nounderline abstract_t">Ritz K, Gerrits MC, Foncke EM, et al. Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry 2009; 80:653.</a></li><li><a class="nounderline abstract_t">Groen JL, Ritz K, Jalalzadeh H, et al. RELN rare variants in myoclonus-dystonia. Mov Disord 2015; 30:415.</a></li><li><a class="nounderline abstract_t">Groen JL, Andrade A, Ritz K, et al. CACNA1B mutation is linked to unique myoclonus-dystonia syndrome. Hum Mol Genet 2015; 24:987.</a></li><li><a class="nounderline abstract_t">Stamelou M, Mencacci NE, Cordivari C, et al. Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency. Neurology 2012; 79:435.</a></li><li><a class="nounderline abstract_t">Grimes DA, Han F, Lang AE, et al. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002; 59:1183.</a></li><li><a class="nounderline abstract_t">Saunders-Pullman R, Shriberg J, Heiman G, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002; 58:242.</a></li><li><a class="nounderline abstract_t">Hess CW, Raymond D, Aguiar Pde C, et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology 2007; 68:522.</a></li><li><a class="nounderline abstract_t">Asmus F, Salih F, Hjermind LE, et al. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann Neurol 2005; 58:792.</a></li><li><a class="nounderline abstract_t">Peall KJ, Smith DJ, Kurian MA, et al. SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 2013; 136:294.</a></li><li><a class="nounderline abstract_t">Müller B, Hedrich K, Kock N, et al. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002; 71:1303.</a></li><li><a class="nounderline abstract_t">Chan P, Gonzalez-Maeso J, Ruf F, et al. Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain. J Comp Neurol 2005; 482:50.</a></li><li><a class="nounderline abstract_t">Thomas JE, Reagan TJ, Klass DW. Epilepsia partialis continua. A review of 32 cases. Arch Neurol 1977; 34:266.</a></li><li><a class="nounderline abstract_t">Delgado-Escueta AV, Medina MT, Bai DS, et al. Genetics of idiopathic myoclonic epilepsies: an overview. Adv Neurol 2002; 89:161.</a></li><li><a class="nounderline abstract_t">Kanai K, Hirose S, Oguni H, et al. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology 2004; 63:329.</a></li><li><a class="nounderline abstract_t">Striano P, Zara F, Striano S. Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. Acta Neurol Scand 2005; 111:211.</a></li><li><a class="nounderline abstract_t">van Rootselaar AF, van Schaik IN, van den Maagdenberg AM, et al. Familial cortical myoclonic tremor with epilepsy: a single syndromic classification for a group of pedigrees bearing common features. Mov Disord 2005; 20:665.</a></li><li><a class="nounderline abstract_t">Coppola A, Santulli L, Del Gaudio L, et al. Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy. Epilepsia 2011; 52:1245.</a></li><li><a class="nounderline abstract_t">Latorre A, Rocchi L, Magrinelli F, et al. Unravelling the enigma of cortical tremor and other forms of cortical myoclonus. Brain 2020; 143:2653.</a></li><li><a class="nounderline abstract_t">Cen Z, Huang C, Yin H, et al. Clinical and neurophysiological features of familial cortical myoclonic tremor with epilepsy. Mov Disord 2016; 31:1704.</a></li><li><a class="nounderline abstract_t">Ishiura H, Doi K, Mitsui J, et al. Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy. Nat Genet 2018; 50:581.</a></li><li><a class="nounderline abstract_t">Alvarez M, Caviness JN. Primary progressive myoclonus of aging. Mov Disord 2008; 23:1658.</a></li><li><a class="nounderline abstract_t">Russell JF, Steckley JL, Coppola G, et al. Familial cortical myoclonus with a mutation in NOL3. Ann Neurol 2012; 72:175.</a></li><li><a class="nounderline abstract_t">Gupta HV, Caviness JN. Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and Treatment. Tremor Other Hyperkinet Mov (N Y) 2016; 6:409.</a></li><li><a class="nounderline abstract_t">Shibasaki H, Hallett M. Electrophysiological studies of myoclonus. Muscle Nerve 2005; 31:157.</a></li><li><a class="nounderline abstract_t">Caviness JN, Truong DD. Myoclonus. Handb Clin Neurol 2011; 100:399.</a></li><li><a class="nounderline abstract_t">Restrepo D, Kochav J, Goodheart AE, et al. The Importance of Identifying Myoclonus in the Setting of Mental Status Abnormalities: Differential Diagnosis and Treatment. Prim Care Companion CNS Disord 2016; 18.</a></li><li><a class="nounderline abstract_t">Zutt R, van Egmond ME, Elting JW, et al. A novel diagnostic approach to patients with myoclonus. Nat Rev Neurol 2015; 11:687.</a></li></ol></div><div id="topicVersionRevision">Topic 4885 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. In: Movement Disorders, Marsden CD, Fahn S (Eds), Butterworths, London 1982. p.196.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15380156" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Myoclonus: current concepts and recent advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15380156" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Myoclonus: current concepts and recent advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1933248" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Intrahemispheric and interhemispheric spread of cerebral cortical myoclonic activity and its relevance to epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16759904" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Generators and temporal succession of giant somatosensory evoked potentials in cortical reflex myoclonus: epicortical recording from sensorimotor cortex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2215948" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Cortical tremor: a variant of cortical reflex myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15508912" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pathophysiology of myoclonic epilepsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7847856" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Basic mechanisms of generalized absence seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16773505" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Functional MRI reveals activation of a subcortical network in a 5-year-old girl with genetically confirmed myoclonus-dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10377930" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The incidence and prevalence of myoclonus in Olmsted County, Minnesota.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3946114" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Nocturnal myoclonus and restless legs syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3946114" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Nocturnal myoclonus and restless legs syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2198400" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Restless legs syndrome and periodic movements of sleep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3080850" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Essential myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12138315" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A case of voluntary palatal myoclonus with ear click: relationship between palatal myoclonus and click.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11018829" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Palatal myoclonus: report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12883939" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Essential palatal myoclonus in monozygotic male twins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9818532" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Continuous, high-frequency objective tinnitus caused by middle ear myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14763331" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Bilateral tinnitus due to middle-ear myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12834120" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Stapedius muscle myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14763328" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Palatal and middle-ear myoclonus: a cause for objective tinnitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22261497" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Systematic review of management strategies for middle ear myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6058147" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hereditary essential myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19117361" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Myoclonus-dystonia: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18362280" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18175340" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17101905" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35723607" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Early recognition of SGCE-myoclonus-dystonia in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3400497" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Myoclonus and dystonia: a family study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8684380" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Essential myoclonus and myoclonic dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14509663" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Inherited myoclonus-dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12874409" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15258227" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Genetic heterogeneity in ten families with myoclonus-dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16227522" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19066193" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Myoclonus-dystonia: clinical and genetic evaluation of a large cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25648840" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : RELN rare variants in myoclonus-dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25296916" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : CACNA1B mutation is linked to unique myoclonus-dystonia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22815559" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12391345" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A novel locus for inherited myoclonus-dystonia on 18p11.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11805251" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17296918" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16240355" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23365103" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : SGCE mutations cause psychiatric disorders: clinical and genetic characterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12444570" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15612018" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/404996" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Epilepsia partialis continua. A review of 32 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11968442" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Genetics of idiopathic myoclonic epilepsies: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15277629" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15740570" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15747356" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Familial cortical myoclonic tremor with epilepsy: a single syndromic classification for a group of pedigrees bearing common features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21426326" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32417917" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Unravelling the enigma of cortical tremor and other forms of cortical myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27613677" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Clinical and neurophysiological features of familial cortical myoclonic tremor with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29507423" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18709679" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Primary progressive myoclonus of aging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22926851" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Familial cortical myoclonus with a mutation in NOL3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27708982" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15547927" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Electrophysiological studies of myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21496598" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Myoclonus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27841934" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The Importance of Identifying Myoclonus in the Setting of Mental Status Abnormalities: Differential Diagnosis and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26553594" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A novel diagnostic approach to patients with myoclonus.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
